Research suggests several beneficial mechanisms: Improved insulin sensitivity : Insulin resistance is a key driver of PCOS symptoms, and GLP-1 medications can enhance insulin action Weight loss effects : Even modest weight reduction (510% of body weight) can restore ovulation and regular cycles in women with PCOS [17] [18] Reduced androgen levels : Weight loss and improved insulin sensitivity often lead to decreased testosterone and other androgens Restoration of ovulation : Some women with PCOS who previously had absent periods may begin ovulating regularly NICE Clinical Knowledge Summary on PCOS recommends lifestyle modification and weight loss as first-line interventions for overweight women with the condition
Francesca Montani and Prof
Size View COA 20mg View COA 30mg View COA 40mg Research reference Overview Retatrutide (LY-3437943) is an investigational triple-receptor agonist that combines activity at the GLP-1, GIP and glucagon receptors in a single 39-residue peptide backbone
Data Privacy Notice: FeelGood's telehealth services involve the collection and processing of sensitive health information by the platform, a licensed medical group (OpenLoop Healthcare Partners, PC), and a third-party compounding pharmacy
A quick guide to the SURPASS and SURMOUNT trials
The GLP-1 patches you may see advertised online or on social media do not contain the same medications found in prescription GLP-1 medications , like semaglutide or tirzepatide